Evaluation of mRNA-1273 against SARS-CoV-2 B. 1.351 infection in nonhuman primates

KS Corbett, AP Werner, S O'Connell, M Gagne, L Lai… - bioRxiv, 2021 - biorxiv.org
Background Vaccine efficacy against the B. 1.351 variant following mRNA-1273 vaccination
in humans has not been determined. Nonhuman primates (NHP) are a useful model for …

Evaluation of mRNA-1273 against SARS-CoV-2 B. 1.351 Infection in Nonhuman Primates

KS Corbett, AP Werner, S O'Connell… - … : the preprint server …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Vaccine efficacy against the B. 1.351 variant following mRNA-1273 vaccination
in humans has not been determined. Nonhuman primates (NHP) are a useful model for …

Evaluation of mRNA-1273 against SARS-CoV-2 B. 1.351 Infection in Nonhuman Primates

KS Corbett, A Werner, M Gagne, J Moliva, B Flynn… - 2021 - pesquisa.bvsalud.org
Evaluation of mRNA-1273 against SARS-CoV-2 B.1.351 Infection in Nonhuman Primates |
PREPRINT-BIORXIV loading 1 2 3 +A A -A 3.Evaluation of mRNA-1273 against SARS-CoV-2 …

Evaluation of mRNA-1273 against SARS-CoV-2 B. 1.351 Infection in Nonhuman Primates

KS Corbett, AP Werner, S O'Connell, M Gagne, L Lai… - bioRxiv - ncbi.nlm.nih.gov
Background Vaccine efficacy against the B. 1.351 variant following mRNA-1273 vaccination
in humans has not been determined. Nonhuman primates (NHP) are a useful model for …

[PDF][PDF] Evaluation of mRNA-1273 against SARS-CoV-2 B. 1.351 Infection in Nonhuman Primates

KS Corbett, AP Werner, S O'Connell, M Gagne… - researchgate.net
Background: Vaccine efficacy against the B. 1.351 variant following mRNA-1273 vaccination
37 in humans has not been determined. Nonhuman primates (NHP) are a useful model for …

Evaluation of mRNA-1273 against SARS-CoV-2 B. 1.351 Infection in Nonhuman Primates.

KS Corbett, AP Werner, S O'Connell… - Biorxiv: the Preprint …, 2021 - europepmc.org
Vaccine efficacy against the B. 1.351 variant following mRNA-1273 vaccination in humans
has not been determined. Nonhuman primates (NHP) are a useful model for demonstrating …

[PDF][PDF] Evaluation of mRNA-1273 against SARS-CoV-2 B. 1.351 Infection in Nonhuman Primates

KS Corbett, AP Werner, S O'Connell, M Gagne… - academia.edu
Background: Vaccine efficacy against the B. 1.351 variant following mRNA-1273 vaccination
37 in humans has not been determined. Nonhuman primates (NHP) are a useful model for …

[PDF][PDF] Evaluation of mRNA-1273 against SARS-CoV-2 B. 1.351 Infection in Nonhuman Primates

KS Corbett, AP Werner, S O'Connell, M Gagne… - researchgate.net
Background: Vaccine efficacy against the B. 1.351 variant following mRNA-1273 vaccination
37 in humans has not been determined. Nonhuman primates (NHP) are a useful model for …

Evaluation of mRNA-1273 against SARS-CoV-2 B. 1.351 Infection in Nonhuman Primates

KS Corbett, AP Werner, S O'Connell, M Gagne, L Lai… - 2021 - europepmc.org
Background Vaccine efficacy against the B. 1.351 variant following mRNA-1273 vaccination
in humans has not been determined. Nonhuman primates (NHP) are a useful model for …

Evaluation of mRNA-1273 against SARS-CoV-2 B. 1.351 Infection in Nonhuman Primates

KS Corbett, A Werner, M Gagne, J Moliva, B Flynn… - 2021 - pesquisa.bvsalud.org
Evaluation of mRNA-1273 against SARS-CoV-2 B.1.351 Infection in Nonhuman Primates |
PREPRINT-BIORXIV loading 1 2 3 +A A -A 3.Evaluation of mRNA-1273 against SARS-CoV-2 …